Dimitri Arangalage, MD *; Julie Delyon, MD *; Mathilde Lermuzeaux, MD; Kenneth Ekpe, MD; Stéphane Ederhy, MD; Cécile Pages, MD; Céleste Lebbé, MD, PhD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L17-0396.
Arangalage D, Delyon J, Lermuzeaux M, Ekpe K, Ederhy S, Pages C, et al. Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors. Ann Intern Med. [Epub ahead of print 5 September 2017]167:683–684. doi: 10.7326/L17-0396
Download citation file:
Published: Ann Intern Med. 2017;167(9):683-684.
Published at www.annals.org on 5 September 2017
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use